Show simple item record

dc.contributor.authorPakhchanian, Haig
dc.contributor.authorKardes, Sinan
dc.contributor.authorKuzu, Ali Suat
dc.contributor.authorKaragulle, Mine
dc.contributor.authorRaiker, Rahul
dc.date.accessioned2021-03-04T13:11:01Z
dc.date.available2021-03-04T13:11:01Z
dc.identifier.citationKardes S., Kuzu A. S. , Pakhchanian H., Raiker R., Karagulle M., "Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends", CLINICAL RHEUMATOLOGY, 2020
dc.identifier.issn0770-3198
dc.identifier.othervv_1032021
dc.identifier.otherav_7b08c221-3afb-4392-bfe3-4dee50119884
dc.identifier.urihttp://hdl.handle.net/20.500.12627/84257
dc.identifier.urihttps://doi.org/10.1007/s10067-020-05490-w
dc.description.abstractIntroduction/objective The general public may utilize online information through search engines for implications and risks of some anti-rheumatic drugs. These drugs have been used in the management of coronavirus disease 2019 (COVID-19) and associated inflammatory sequelae or cytokine storm of infection. Therefore, the objective of this study was to investigate the population-level interest in anti-rheumatic drugs during the COVID-19 era, by analyzing changes in Google search frequency data.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.subjectROMATOLOJİ
dc.titlePopulation-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends
dc.typeMakale
dc.relation.journalCLINICAL RHEUMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.contributor.firstauthorID2358211


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record